- Home
- KPRX vs VVPR Comparison
KPRX vs VVPR Comparison
Compare KPRX & VVPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- VVPR
- Stock Information
- Founded
- KPRX 1998
- VVPR 2014
- Country
- KPRX United States
- VVPR United Kingdom
- Employees
- KPRX N/A
- VVPR N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VVPR Power Generation
- Sector
- KPRX Health Care
- VVPR Utilities
- Exchange
- KPRX Nasdaq
- VVPR Nasdaq
- Market Cap
- KPRX 12.0M
- VVPR 10.9M
- IPO Year
- KPRX N/A
- VVPR 2016
- Fundamental
- Price
- KPRX $3.47
- VVPR $0.79
- Analyst Decision
- KPRX Strong Buy
- VVPR
- Analyst Count
- KPRX 1
- VVPR 0
- Target Price
- KPRX $10.00
- VVPR N/A
- AVG Volume (30 Days)
- KPRX 46.3K
- VVPR 125.8K
- Earning Date
- KPRX 03-24-2025
- VVPR 01-01-0001
- Dividend Yield
- KPRX N/A
- VVPR N/A
- EPS Growth
- KPRX N/A
- VVPR N/A
- EPS
- KPRX 1.69
- VVPR N/A
- Revenue
- KPRX $16,020,000.00
- VVPR $79,000.00
- Revenue This Year
- KPRX N/A
- VVPR N/A
- Revenue Next Year
- KPRX N/A
- VVPR N/A
- P/E Ratio
- KPRX $2.05
- VVPR N/A
- Revenue Growth
- KPRX N/A
- VVPR N/A
- 52 Week Low
- KPRX $3.00
- VVPR $0.72
- 52 Week High
- KPRX $6.75
- VVPR $9.90
- Technical
- Relative Strength Index (RSI)
- KPRX 44.69
- VVPR 28.51
- Support Level
- KPRX $3.40
- VVPR $0.74
- Resistance Level
- KPRX $3.75
- VVPR $0.84
- Average True Range (ATR)
- KPRX 0.22
- VVPR 0.09
- MACD
- KPRX -0.03
- VVPR -0.02
- Stochastic Oscillator
- KPRX 37.65
- VVPR 11.48
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About VVPR VivoPower International PLC
Vivopower International PLC is a solar power company. The company provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Critical Power Services segment which consists of the design, supply, installation, and maintenance of power and control systems. It provides its solutions to government, commercial, and industrial customers. Nearly all of the revenue derives from Australia.